‌

US Patent 11530217 Antitubercular compounds

Patent 11530217 was granted and assigned to King Faisal University on December, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

King Faisal University

Current Assignee

King Faisal University

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

115302170

Patent Inventor Names

Sandeep Chandrashekharappa0

Mahesh Attimarad0

Melendran Pillay0

Mohamed A. Morsy0

Nagaraja Sreeharsha0

Pran Kishore Deb0

Anroop B. Nair0

Katharigatta N. Venugopala0

Date of Patent

December 20, 2022

Patent Application Number

178536180

Date Filed

June 29, 2022

Patent Citations

‌

US Patent 10435402 Bicyclic compounds, compositions and medicinal applications thereof

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11530217 Antitubercular compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API